Search Results - "Anh, T. Le"
-
1
TRKing down an old oncogene in a new era of targeted therapy
Published in Cancer discovery (01-01-2015)“…The use of high-throughput next-generation sequencing techniques in multiple tumor types during the last few years has identified NTRK1, 2, and 3 gene…”
Get more information
Journal Article -
2
Lignin degradation by microorganisms: A review
Published in Biotechnology progress (01-03-2022)“…Lignin is an abundant plant‐based biopolymer that has found applications in a variety of industries from construction to bioethanol production. This…”
Get full text
Journal Article -
3
Environmental impact of bioplastic use: A review
Published in Heliyon (01-09-2021)“…Throughout their lifecycle, petroleum-based plastics are associated with many environmental problems, including greenhouse gas emissions, persistence in marine…”
Get full text
Journal Article -
4
Policy Responses to the COVID-19 Pandemic in Vietnam
Published in International journal of environmental research and public health (11-01-2021)“…The COVID-19 pandemic has become one of the most serious health crises in human history, spreading rapidly across the globe from January 2020 to the present…”
Get full text
Journal Article -
5
Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer
Published in Nature medicine (01-05-2018)“…Although most activating mutations of epidermal growth factor receptor (EGFR)-mutant non–small cell lung cancers (NSCLCs) are sensitive to available EGFR…”
Get full text
Journal Article -
6
Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples
Published in Journal of thoracic oncology (01-10-2018)“…ROS1 gene fusions are a well-characterized class of oncogenic driver found in approximately 1% to 2% of NSCLC patients. ROS1-directed therapy in these patients…”
Get more information
Journal Article -
7
Resistance Mechanisms to Targeted Therapies in ROS1 + and ALK + Non-small Cell Lung Cancer
Published in Clinical cancer research (15-07-2018)“…Despite initial benefit from tyrosine kinase inhibitors (TKIs), patients with advanced non-small cell lung cancer (NSCLC) harboring (ALK ) and (ROS1 ) gene…”
Get full text
Journal Article -
8
Clinical Utility of Cell-Free DNA for the Detection of ALK Fusions and Genomic Mechanisms of ALK Inhibitor Resistance in Non-Small Cell Lung Cancer
Published in Clinical cancer research (15-06-2018)“…Patients with advanced non-small cell lung cancer (NSCLC) whose tumors harbor anaplastic lymphoma kinase ( gene fusions benefit from treatment with ALK…”
Get full text
Journal Article -
9
Identifying and Targeting ROS1 Gene Fusions in Non―Small Cell Lung Cancer
Published in Clinical cancer research (01-09-2012)“…Oncogenic gene fusions involving the 3' region of ROS1 kinase have been identified in various human cancers. In this study, we sought to characterize ROS1…”
Get full text
Journal Article -
10
Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes
Published in Clinical cancer research (01-03-2021)“…Approved therapies for exon 20, mutations, and fusions are currently lacking for non-small cell lung cancer and other cancers. Tarloxotinib is a prodrug that…”
Get full text
Journal Article -
11
An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer
Published in Journal of thoracic oncology (01-08-2016)“…Patients with non-small cell lung cancer (NSCLC) harboring ROS proto-oncogene 1, receptor tyrosine kinase gene (ROS1) chromosomal rearrangements benefit from…”
Get more information
Journal Article -
12
Resistance to ROS1 inhibition mediated by EGFR pathway activation in non-small cell lung cancer
Published in PloS one (13-12-2013)“…The targeting of oncogenic 'driver' kinases with small molecule inhibitors has proven to be a highly effective therapeutic strategy in selected non-small cell…”
Get full text
Journal Article -
13
Resistance to RET-Inhibition in RET-Rearranged NSCLC Is Mediated By Reactivation of RAS/MAPK Signaling
Published in Molecular cancer therapeutics (01-08-2017)“…Oncogenic rearrangements in are present in 1%-2% of lung adenocarcinoma patients. Ponatinib is a multi-kinase inhibitor with low-nanomolar potency against the…”
Get full text
Journal Article -
14
Household-Contact Investigation for Detection of Tuberculosis in Vietnam
Published in The New England journal of medicine (18-01-2018)“…Tuberculosis continues to be a global health challenge. In this report, active case finding was more than twice as likely as standard passive case finding to…”
Get full text
Journal Article -
15
EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Oncogenic kinase fusions of , , , and act as drivers in human lung and other cancers. Residual tumor burden following treatment of ALK or ROS1 lung cancer…”
Get full text
Journal Article -
16
Genotypic and Phenotypic Diversity of Endemic Golden Camellias Collected from the North of Vietnam
Published in Chemistry & biodiversity (01-01-2023)“…Golden Camellias have recently been used as a food, cosmetic, and traditional medicine in China and Vietnam. Forty‐two species have natural distribution in…”
Get full text
Journal Article -
17
Investigating the determinants and process of destination management system (DMS) implementation
Published in Journal of organizational change management (25-03-2022)“…PurposeThis study aims to propose a comprehensive model to help understand factors influencing the intention to participate in a destination management system…”
Get full text
Journal Article -
18
Design, synthesis, and ex vivo evaluation of a selective inhibitor for retinaldehyde dehydrogenase enzymes
Published in Bioorganic & medicinal chemistry (01-12-2018)“…[Display omitted] The retinaldehyde dehydrogenase (RALDH) enzymes, RALDH1, RALDH2, and RALDH3, catalyze the irreversible oxidation of retinaldehyde to…”
Get full text
Journal Article -
19
Payments for ecosystem services programs: A global review of contributions towards sustainability
Published in Heliyon (15-01-2024)“…Payments for ecosystem services programs (PESPs) are increasingly being adopted globally to enhance sustainability outcomes. There are also hundreds of studies…”
Get full text
Journal Article -
20
High dose acetaminophen inhibits STAT3 and has free radical independent anti-cancer stem cell activity
Published in Neoplasia (New York, N.Y.) (01-03-2021)“…High-dose acetaminophen (AAP) with delayed rescue using n-acetylcysteine (NAC), the FDA-approved antidote to AAP overdose, has demonstrated promising antitumor…”
Get full text
Journal Article